TY - JOUR T1 - Pretreatment with Interferon-α Radiosensitizes Daudi Cells Modulating Gene Expression and Biomarkers JF - Anticancer Research JO - Anticancer Res SP - 2631 LP - 2638 VL - 25 IS - 4 AU - JUNKO HORIGUCHI-YAMADA AU - SATSUKI IWASE AU - TAKESHI KAWANO AU - HISASHI YAMADA Y1 - 2005/07/01 UR - http://ar.iiarjournals.org/content/25/4/2631.abstract N2 - Background: Interferon (IFN) potentiates cytotoxicity by X-ray irradiation. To elucidate the mechanism of this potentiation, the biological markers related to DNA damage and cell survival were studied. Materials and Methods: IFN-α-sensitive Daudi and its resistant cells were used. Survival after treatment was assessed by clonogenic assays. DNA breaks were studied by pulse-field gel electrophoresis (PFGE). Production of reactive oxygen metabolites was measured using flow cytometry. Messenger RNA and protein were examined by RT-PCR and immunoblot, respectively. Results: IFN-α treatment for 24 h before irradiation potentiated the sensitivity of Daudi cells to X-rays. This combination induced 50 kb DNA fragmentation and activated caspase-3 in Daudi cells. Pretreatment with IFN-α inhibited the production of reactive oxygen species by irradiation. IFN-α pretreatment down-regulated most of the double-strand break (DSB) repair-related mRNAs, but did not affect the repair of DSBs studied by PFGE. The induction and phosphorylation of p21Cip1/WAF1 (p21) was prominently suppressed in cells pretreated with IFN-α. Conclusion: Pretreatment with IFN-α potentiates the cytotoxic effects of X-rays. Inhibition of X-ray-induced p21 may cause the augmented sensitivity by IFN-α pretreatment. Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved ER -